Author： Schumacher G.E. Barr J.T.
Publisher： Adis International
ISSN： 0312-5963
Source： Clinical Pharmacokinetics, Vol.40, Iss.6, 2001-01, pp. : 405-409
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Do reference-based pricing policies really contain drug costs?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 320, 2001-01 ,pp. :
Access to resources
Recommend
Pay for performance an ethical way to contain drug costs?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 570, 2009-01 ,pp. :
Is DM a recipe for containing costs?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 271, 2000-01 ,pp. :
Is There a Role for Therapeutic Drug Monitoring of New Anticonvulsants?
By Perucca E.
Clinical Pharmacokinetics, Vol. 38, Iss. 3, 2000-03 ,pp. :
Pharmacogenetics: The Therapeutic Drug Monitoring of the Future?
By Ensom M.H.H.
Clinical Pharmacokinetics, Vol. 40, Iss. 11, 2001-01 ,pp. :